Cvs Pharmacy #00513 Durable Medical Equipment & Medical Supplies Location: 252 Broadway, Raynham, Massachusetts 02767 Phone: (508) 824-8621 |
Cvs Pharmacy #00335 Durable Medical Equipment & Medical Supplies Location: 266 Route 44, Raynham, Massachusetts 02767 Phone: (508) 824-1361 |
Walmart Pharmacy 10-2021 Durable Medical Equipment & Medical Supplies Location: 36 Paramount Dr, Raynham, Massachusetts 02767 Phone: (508) 822-7122 |
Walmart Pharmacy 10-5448 Durable Medical Equipment & Medical Supplies Location: 160 Broadway, Raynham, Massachusetts 02767 Phone: (508) 692-6751 |
News Archive
Southwest Bancorp, Inc., today announced that it has priced its underwritten public offering of 4,000,000 shares of common stock at a price to the public of $12.50 per share for net proceeds of approximately $47.0 million. The offering was increased from the previously announced offering size of approximately $40 million. The offering is expected to close on April 29, 2010.
Temperatures taken orally or by temporal artery thermometry "are an accurate means of temperature assessment for adult patients undergoing colorectal or gynecology surgery," according to analysis published by the Journal of PeriAnesthesia Nursing. Accurate temperature readings are necessary to determine when to intervene for patients at all stages of their hospitalizations but especially during and immediately after surgical procedures to avoid post-operative complications.
A statistical modeling study suggests that problems with alcohol abuse may lead to an increased risk of depression, as opposed to the reverse model in which individuals with depression self-medicate with alcohol, according to a report in the March issue of Archives of General Psychiatry.
Following significant advances in vaccine and microbicide research, including results presented today of 39% efficacy in the CAPRISA 004 microbicide gel trial among women in South Africa, a new report released today warns that flat funding for HIV prevention research may limit researchers' ability to quickly move promising approaches forward.
Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that the peer-reviewed journal Molecular Therapy has published a paper entitled "Comparative Analysis of Immune Responses Induced by Vaccination With SIV Antigens by Recombinant Ad5 Vector or Plasmid DNA in Rhesus Macaques." The paper, co-authored by researchers from Merck, University of Pennsylvania School of Medicine, and Inovio Pharmaceuticals, notes that significant advances in the design, formulation, and delivery of DNA plasmid-based vaccines have dramatically increased their ability to induce antigen-specific immune responses.
› Verified 9 days ago